These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. C-terminal domain (CTD) small phosphatase-like 2 modulates the canonical bone morphogenetic protein (BMP) signaling and mesenchymal differentiation via Smad dephosphorylation. Zhao Y; Xiao M; Sun B; Zhang Z; Shen T; Duan X; Yu PB; Feng XH; Lin X J Biol Chem; 2014 Sep; 289(38):26441-26450. PubMed ID: 25100727 [TBL] [Abstract][Full Text] [Related]
3. BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype. Phimphilai M; Zhao Z; Boules H; Roca H; Franceschi RT J Bone Miner Res; 2006 Apr; 21(4):637-46. PubMed ID: 16598384 [TBL] [Abstract][Full Text] [Related]
4. Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2. Sowa H; Kaji H; Hendy GN; Canaff L; Komori T; Sugimoto T; Chihara K J Biol Chem; 2004 Sep; 279(39):40267-75. PubMed ID: 15150273 [TBL] [Abstract][Full Text] [Related]
5. Regulation of Id1 expression by SRC: implications for targeting of the bone morphogenetic protein pathway in cancer. Gautschi O; Tepper CG; Purnell PR; Izumiya Y; Evans CP; Green TP; Desprez PY; Lara PN; Gandara DR; Mack PC; Kung HJ Cancer Res; 2008 Apr; 68(7):2250-8. PubMed ID: 18381431 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of ID protein by growth and differentiation factor 5 (GDF5) through a smad-dependent and MAPK-independent pathway in HUVSMC. Chen X; Zankl A; Niroomand F; Liu Z; Katus HA; Jahn L; Tiefenbacher C J Mol Cell Cardiol; 2006 Jul; 41(1):26-33. PubMed ID: 16716349 [TBL] [Abstract][Full Text] [Related]
9. Activation of the BMP canonical signaling pathway in human optic nerve head tissue and isolated optic nerve head astrocytes and lamina cribrosa cells. Zode GS; Clark AF; Wordinger RJ Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5058-67. PubMed ID: 17962458 [TBL] [Abstract][Full Text] [Related]
10. Smad-dependent and smad-independent induction of id1 by prostacyclin analogues inhibits proliferation of pulmonary artery smooth muscle cells in vitro and in vivo. Yang J; Li X; Al-Lamki RS; Southwood M; Zhao J; Lever AM; Grimminger F; Schermuly RT; Morrell NW Circ Res; 2010 Jul; 107(2):252-62. PubMed ID: 20522807 [TBL] [Abstract][Full Text] [Related]
11. SANE, a novel LEM domain protein, regulates bone morphogenetic protein signaling through interaction with Smad1. Raju GP; Dimova N; Klein PS; Huang HC J Biol Chem; 2003 Jan; 278(1):428-37. PubMed ID: 12393873 [TBL] [Abstract][Full Text] [Related]
12. Cross-talk between Wnt and bone morphogenetic protein 2 (BMP-2) signaling in differentiation pathway of C2C12 myoblasts. Nakashima A; Katagiri T; Tamura M J Biol Chem; 2005 Nov; 280(45):37660-8. PubMed ID: 16150699 [TBL] [Abstract][Full Text] [Related]
13. Focal adhesion kinase activity is required for bone morphogenetic protein--Smad1 signaling and osteoblastic differentiation in murine MC3T3-E1 cells. Tamura Y; Takeuchi Y; Suzawa M; Fukumoto S; Kato M; Miyazono K; Fujita T J Bone Miner Res; 2001 Oct; 16(10):1772-9. PubMed ID: 11585340 [TBL] [Abstract][Full Text] [Related]
15. Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12. Nishimura R; Kato Y; Chen D; Harris SE; Mundy GR; Yoneda T J Biol Chem; 1998 Jan; 273(4):1872-9. PubMed ID: 9442019 [TBL] [Abstract][Full Text] [Related]
16. Specific control of BMP signaling and mesenchymal differentiation by cytoplasmic phosphatase PPM1H. Shen T; Sun C; Zhang Z; Xu N; Duan X; Feng XH; Lin X Cell Res; 2014 Jun; 24(6):727-41. PubMed ID: 24732009 [TBL] [Abstract][Full Text] [Related]
17. Endofin acts as a Smad anchor for receptor activation in BMP signaling. Shi W; Chang C; Nie S; Xie S; Wan M; Cao X J Cell Sci; 2007 Apr; 120(Pt 7):1216-24. PubMed ID: 17356069 [TBL] [Abstract][Full Text] [Related]
18. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5. Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852 [TBL] [Abstract][Full Text] [Related]
19. Bone morphogenetic protein activities are enhanced by 3',5'-cyclic adenosine monophosphate through suppression of Smad6 expression in osteoprogenitor cells. Sugama R; Koike T; Imai Y; Nomura-Furuwatari C; Takaoka K Bone; 2006 Feb; 38(2):206-14. PubMed ID: 16203197 [TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development. Okamoto M; Murai J; Yoshikawa H; Tsumaki N J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]